SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinase

Molecular and Cellular Neuroscience

Volumn 37, Issue 2, 2008, Pages 367-375

  Miao, Tizong ^a   Wu, Dongsheng ^a   Zhang, Yi ^a   Bo, Xuenong ^a   Xiao, Fang ^b   Zhang, Xinyu ^a   Magoulas, Charalambos ^a   Subang, Maria Cristina ^a   Wang, Ping ^a   Richardson, Peter M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AP 1; JIP 1; JNK; SOCS3; STAT3; VIP

Indexed keywords

AMINO ACID; CILIARY NEUROTROPHIC FACTOR; MESSENGER RNA; SCAFFOLD PROTEIN; STAT PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; MUTANT; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; CILIARY NEUROTROPHIC FACTOR; DOWN-REGULATION; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; NEUROBLASTOMA; NEURONS; PHOSPHORYLATION; RATS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 38649143105     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.10.010     Document Type: Article

References (46)

1. Arguni E., Arima M., Tsuruoka N., Sakamoto A., Hatano M., and Tokuhisa T. JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells. Int. Immunol. 18 (2006) 1079-1089
2. Babon J.J., McManus E.J., Yao S., DeSouza D.P., Mielke L.A., Sprigg N.S., Willson T.A., Hilton D.J., Nicola N.A., Baca M., Nicholson S.E., and Norton R.S. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. Mol. Cell 22 (2006) 205-216
3. Banerjee A., Banks A.S., Nawijn M.C., Chen X.P., and Rothman P.B. Cutting edge: suppressor of cytokine signaling 3 inhibits activation of NFATp. J. Immunol. 168 (2002) 4277-4281
4. Bartoe J.L., and Nathanson N.M. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor. Brain Res. Mol. Brain Res. 107 (2002) 108-119
5. Bousquet C., Zatelli M.C., and Melmed S. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J. Clin. Invest. 106 (2000) 1417-1425
6. Bugno M., Graeve L., Gatsios P., Koj A., Heinrich P.C., Travis J., and Kordula T. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res. 23 (1995) 5041-5047
7. Cacalano N.A., Sanden D., and Johnston J.A. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3 (2001) 460-465
8. Coffer P., Lutticken C., van Puijenbroek A., Klop-de Jonge M., Horn F., and Kruijer W. Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction. Oncogene 10 (1995) 985-994
9. Croker B.A., Metcalf D., Robb L., Wei W., Mifsud S., DiRago L., Cluse L.A., Sutherland K.D., Hartley L., Williams E., Zhang J.G., Hilton D.J., Nicola N.A., Alexander W.S., and Roberts A.W. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20 (2004) 153-165
10. Dauer D.J., Ferraro B., Song L., Yu B., Mora L., Buettner R., Enkemann S., Jove R., and Haura E.B. Stat3 regulates genes common to both wound healing and cancer. Oncogene 24 (2005) 3397-3408
11. Decker T., Kovarik P., and Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17 (1997) 121-134
12. Emery B., Cate H.S., Marriott M., Merson T., Binder M.D., Snell C., Soo P.Y., Murray S., Croker B., Zhang J.G., Alexander W.S., Cooper H., Butzkueven H., and Kilpatrick T.J. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7859-7864
13. Frobose H., Ronn S.G., Heding P.E., Mendoza H., Cohen P., Mandrup-Poulsen T., and Billestrup N. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20 (2006) 1587-1596
14. Gupta S.K., Altares M., Benoit R., Riopelle R.J., Dunn R.J., and Richardson P.M. Preparation and biological properties of native and recombinant ciliary neurotrophic factor. J. Neurobiol. 23 (1992) 481-490
15. Hahm S.H., and Eiden L.E. Two separate cis-active elements of the vasoactive intestinal peptide gene mediate constitutive and inducible transcription by binding different sets of AP-1 proteins. J. Biol. Chem. 274 (1999) 25588-25593
16. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
17. Higashi N., Kunimoto H., Kaneko S., Sasaki T., Ishii M., Kojima H., and Nakajima K. Cytoplasmic c-Fos induced by the YXXQ-derived STAT3 signal requires the co-operative MEK/ERK signal for its nuclear translocation. Genes Cells 9 (2004) 233-242
18. Jenab S., and Morris P.L. Transcriptional regulation of Sertoli cell immediate early genes by interleukin-6 and interferon-gamma is mediated through phosphorylation of STAT-3 and STAT-1 proteins. Endocrinology 138 (1997) 2740-2746
19. Jones E.A., Conover J., and Symes A.J. Identification of a novel gp130-responsive site in the vasoactive intestinal peptide cytokine response element. J. Biol. Chem. 275 (2000) 36013-36020
20. Kenney A.M., and Kocsis J.D. Peripheral axotomy induces long-term c-jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-jun and junD in adult rat dorsal root ganglia in vivo. J. Neurosci. (1998) 1318-1328
21. Lang R., Pauleau A.L., Parganas E., Takahashi Y., Mages J., Ihle J.N., Rutschman R., and Murray P.J. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4 (2003) 546-550
22. Leu J.I., Crissey M.A., Leu J.P., Ciliberto G., and Taub R. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol. Cell. Biol. 21 (2001) 414-424
23. Liu E., Cote J.F., and Vuori K. Negative regulation of FAK signaling by SOCS proteins. EMBO J. 22 (2003) 5036-5046
24. Matsuda T., Nakamura T., Nakao K., Arai T., Katsuki M., Heike T., and Yokota T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18 (1999) 4261-4269
25. Miao T., Wu D., Zhang Y., Bo X., Subang M.C., Wang P., and Richardson P.M. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J. Neurosci. 26 (2006) 9512-9519
26. Milocco L.H., Haslam J.A., Rosen J., and Seidel H.M. Design of conditionally active STATs: insights into STAT activation and gene regulatory function. Mol. Cell. Biol. 19 (1999) 2913-2920
27. Pitts R.L., Wang S., Jones E.A., and Symes A.J. Transforming growth factor-beta and ciliary neurotrophic factor synergistically induce vasoactive intestinal peptide gene expression through the cooperation of Smad, STAT, and AP-1 sites. J. Biol. Chem. 276 (2001) 19966-19973
28. Qiu J., Cafferty W.B., McMahon S.B., and Thompson S.W. Conditioning injury-induced spinal axon regeneration requires signal transducer and activator of transcription 3 activation. J. Neurosci. 25 (2005) 1645-1653
29. Raivich G., and Behrens A. Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog. Neurobiol. 78 (2006) 347-363
30. Raivich G., Bohatschek M., Da Costa C., Iwata O., Galiano M., Hristova M., Nateri A.S., Makwana M., Riera-Sans L., Wolfer D.P., Lipp H.P., Aguzzi A., Wagner E.F., and Behrens A. The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43 (2004) 57-67
31. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
32. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132 (2000) 365-386
33. Rui L., Yuan M., Frantz D., Shoelson S., and White M.F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277 (2002) 42394-42398
34. Sasaki A., Yasukawa H., Shouda T., Kitamura T., Dikic I., and Yoshimura A. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J. Biol. Chem. 275 (2000) 29338-29347
35. Schaefer T.S., Sanders L.K., and Nathans D. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9097-9101
36. Schuringa J.J., Timmer H., Luttickhuizen D., Vellenga E., and Kruijer W. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 response element (IRE). Cytokine 14 (2001) 78-87
37. Schwaiger F.-W., Hager G., Schmitt A.B., Horvat A., Streif R., Spitzer C., Gamal S., Breuer S., Brook G.A., Nacimiento W., and Kreutzberg G. Peripheral but not central axotomy induces changes in janus kinases and signal transducers and activators of transcription. Eur. J. Neurosci. 12 (2000) 1165-1176
38. Symes A.J., Rao M.S., Lewis S.E., LAndis S.C., Hyman S.E., and Fink J.S. Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 572-576
39. Symes A., Gearan T., Eby J., and Fink J.S. Integration of Jak-Stat and AP-1 signaling pathways at the vasoactive intestinal peptide cytokine response element regulates ciliary neurotrophic factor-dependent transcription. J. Biol. Chem. 272 (1997) 9648-9654
40. Ueki K., Kondo T., and Kahn C.R. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol. 24 (2004) 5434-5446
41. Waetzig V., and Herdegen T. A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell death. J. Biol. Chem. 278 (2003) 567-572
42. Waetzig V., and Herdegen T. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol. Sci. 26 (2005) 455-461
43. Whitmarsh A.J. The JIP family of MAPK scaffold proteins. Biochem. Soc. Trans. 34 (2006) 828-832
44. Yang E., Lerner L., Besser D., and Darnell Jr. J.E. Independent and cooperative activation of chromosomal c-fos promoter by STAT3. J. Biol. Chem. 278 (2003) 15794-15799
45. Yasukawa H., Misawa H., Sakamoto H., Masuhara M., Sasaki A., Wakioka T., Ohtsuka S., Imaizumi T., Matsuda T., Ihle J.N., and Yoshimura A. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18 (1999) 1309-1320
46. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., Hanada T., Takeda K., Akira S., Hoshijima M., Hirano T., Chien K.R., and Yoshimura A. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4 (2003) 551-556